查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1587616

到 2030 年人工器官和仿生市場預測：按產品、材料、分銷管道、技術、應用、最終用戶和地區進行的全球分析

Artificial Organs and Bionic Market Forecasts to 2030 - Global Analysis By Product (Artificial Organs and Bionic Devices), Material (Biomaterials, Metals, Polymers and Ceramics), Distribution Channel, Technology, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據Stratistics MRC預測，2024年全球人造器官和仿生市場規模將達到424億美元，預計2030年將達到807億美元，預測期內複合年成長率為11.3%。

人造器官是一種旨在重現自然器官功能並為器官衰竭或功能障礙患者提供治療解決方案的人工裝置。另一方面，仿生學是指生物系統和機械部件的整合，通常透過技術增強或恢復人類的能力。這兩個領域都旨在提高生活品質，人造器官著重於器官替代，仿生學著重於增強身體表現，代表了醫學和工程學的重要進步。

根據 HRSA 的數據，2022 年，65 歲及以上族群進行了 8,895 例器官移植手術，比 2021 年增加了 3.7%，達到 42,887 例。

器官移植需求不斷成長

器官移植需求的不斷成長正在顯著推動市場發展。慢性疾病增加、人口老化和捐贈器官嚴重短缺等因素強調需要創新解決方案。人造器官為患者提供了重要的替代方案，仿生技術正在提高移動性和功能性。需求的激增正在推動旨在改善患者治療效果和擴大可用治療方法範圍的進步。

監管挑戰

市場上的監管挑戰包括嚴格的核准流程，以確保產品到達消費者之前的安全性和有效性。了解 FDA 等機構的複雜指導方針可能會減緩創新和市場進入。此外，各國的法規各不相同，使得全球合作和標準化變得複雜。這些障礙可能會阻礙救生技術的快速發展，因此相關人員必須與監管機構合作，在保持安全標準的同時簡化流程。

慢性病增加

糖尿病、心臟病和腎衰竭等慢性病的盛行率不斷上升，推動了市場需求。由於這些疾病導致器官功能障礙，對人造器官和仿生設備等創新解決方案的需求變得更加重要。這一趨勢凸顯了技術進步對於加強患者護理、提高生活品質以及應對日益成長的慢性健康問題人口帶來的挑戰的重要性。

有限的外科專業知識

有限的外科專業知識是這個市場的主要挑戰。植入和管理先進技術的複雜性需要高度專業化的技能，而這些技能可能無法廣泛使用，特別是在服務不足的地區。這種短缺可能會導致患者無法獲得緊急醫療設備，從而阻礙整體市場成長。透過有針對性的培訓和教育來彌補這一差距對於提高手術能力和改善患者治療效果至關重要。

COVID-19 的影響

COVID-19 大流行擾亂了供應鏈並推遲了研發計劃，對市場產生了重大影響。醫院優先考慮急性護理，導致涉及義肢裝置的選擇性手術被推遲。然而，這場大流行加速了人們對創新醫療解決方案的興趣，並凸顯了對先進技術來解決病毒加劇的慢性疾病的需求。隨著醫療保健優先事項的發展，這種變化可能會推動該領域的未來成長和投資。

生物工程領域預計將在預測期內成為最大的領域

由於慢性病和器官短缺的增加，生物工程領域預計將在預測期內佔據最大的市場佔有率。這些創新旨在模仿自然器官功能，同時解決器官稀缺和排斥等問題。透過將生物材料和工程原理相結合，生物工程產品提供了個人化醫療的潛力，改善了患者的治療效果，並為再生醫學中更有效的治療鋪平了道路。

預計醫院領域在預測期內的複合年成長率最高。

預計醫院部門在預測期內將呈現最高的複合年成長率。醫院對於臨床測試至關重要，新技術在這裡得到測試和改進。此外，醫院擴大部署先進的人造器官和仿生設備來改善治療效果，尤其是慢性病患者。這一趨勢推動了對創新解決方案的需求，並凸顯了醫院在醫療技術進步中的關鍵地位。

比最大的地區

由於先進的醫療基礎設施、高額研發投資以及慢性病發病率上升，預計北美地區將在預測期內佔據最大的市場佔有率。主要企業和創新新興企業處於技術進步的最前沿，專注於人造器官和仿生設備。此外，支持性的政府政策以及對患者護理和個人化醫療的大力關注正在進一步支持該地區的市場擴張。

複合年成長率最高的地區

在殘障人士人數增加的推動下，預計亞太地區在預測期內將實現最高成長率。該市場包括心臟和腎臟等人造器官以及人工電子耳和整形外科仿生等仿生設備等各個領域。醫療機構、大學和私人公司之間為增強產品供應和改善患者治療效果而進行的合作進一步推動了對這些創新的需求。

免費客製化服務

訂閱此報告的客戶可以存取以下免費自訂選項之一：

  • 公司簡介
    • 其他市場參與企業的綜合分析（最多 3 家公司）
    • 主要企業SWOT分析（最多3家企業）
  • 區域分割
    • 根據客戶興趣對主要國家的市場估計/預測/複合年成長率（註：基於可行性檢查）
  • 競爭標基準化分析
    • 按產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第2章 前言

  • 概述
  • 相關利益者
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 資料分析
    • 資料檢驗
    • 研究途徑
  • 研究資訊來源
    • 主要研究資訊來源
    • 二次研究資訊來源
    • 先決條件

第3章市場趨勢分析

  • 介紹
  • 促進因素
  • 抑制因素
  • 機會
  • 威脅
  • 產品分析
  • 技術分析
  • 應用分析
  • 最終用戶分析
  • 新興市場
  • COVID-19 的影響

第4章波特五力分析

  • 供應商的議價能力
  • 買方議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭公司之間的敵對關係

第5章全球人造器官與仿生市場：依產品

  • 介紹
  • 人造器官
    • 人工胰臟
    • 人工心臟
    • 人工肺
    • 人工腎
    • 人工肝
  • 仿生裝置
    • 義肢
    • 仿生眼
    • 人工電子耳
    • 神經介面

第6章全球人造器官與仿生市場：依材料分類

  • 介紹
  • 生物材料
  • 金屬
  • 聚合物
  • 陶瓷製品

第7章全球人造器官與仿生市場：依通路分類

  • 介紹
  • 直銷
  • 第三方賣家
  • 網路平台

第8章全球人造器官與仿生市場：依技術分類

  • 介紹
  • 傳統的
  • 生物工程
  • 再生醫學
  • 基於奈米科技
  • 其他

第9章全球人造器官與仿生市場：依應用分類

  • 介紹
  • 慢性病
  • 外傷和損傷
  • 整容手術
  • 神經假體
  • 其他

第10章全球人造器官和仿生市場：依最終用戶分類

  • 介紹
  • 醫院
  • 門診手術中心
  • 居家醫療
  • 復健中心
  • 其他

第11章全球人造器官與仿生市場：按地區

  • 介紹
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 歐洲其他地區
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東/非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東/非洲

第12章 主要進展

  • 合約、夥伴關係、協作和合資企業
  • 收購和合併
  • 新產品發布
  • 業務拓展
  • 其他關鍵策略

第13章 公司概況

  • Medtronic Plc.
  • Boston Scientific Corporation
  • IVIVA Medical
  • SynCardia Systems, LLC
  • Ekso Bionics
  • Edwards Lifesciences Corporation
  • ABIOMED
  • Berlin Heart
  • Cochlear Ltd.
  • Jarvik Heart, Inc
  • Zimmer Biomet
  • Smith & Nephew
  • Kangaroo Health
  • Cyberdyne
  • Hanger Clinic
Product Code: SMRC27601

According to Stratistics MRC, the Global Artificial Organs and Bionic Market is accounted for $42.4 billion in 2024 and is expected to reach $80.7 billion by 2030 growing at a CAGR of 11.3% during the forecast period. Artificial organs are engineered devices designed to replicate the functions of natural organs, providing therapeutic solutions for individuals with organ failure or dysfunction. Bionics, on the other hand, refers to the integration of biological systems with mechanical components, often enhancing or restoring human capabilities through technology. Both fields aim to improve quality of life, with artificial organs focusing on organ replacement and bionics enhancing physical abilities, representing significant advancements in medical science and engineering.

According to the HRSA, in 2022, there were 8,895 organ transplant procedures performed on the population aged over 65 in the U.S. In 2022, 42,887 organ transplants were performed in the U.S., an increase of 3.7 percent over 2021.

Market Dynamics:

Driver:

Increasing demand for organ transplants

The growing demand for organ transplants is significantly boosting the market. Factors such as rising chronic diseases, an aging population, and a critical shortage of donor organs underscore the need for innovative solutions. Artificial organs provide vital alternatives for patients, while bionic technologies enhance mobility and functionality. This surge in demand is driving advancements aimed at improving patient outcomes and expanding the range of available treatments.

Restraint:

Regulatory challenges

Regulatory challenges in the market include stringent approval processes, ensuring safety and efficacy before products reach consumers. Navigating complex guidelines from agencies like the FDA can delay innovation and market entry. Additionally, varying regulations across countries complicate global collaboration and standardization. These hurdles can hinder the rapid development of life-saving technologies, making it essential for stakeholders to engage with regulators to streamline processes while maintaining safety standards.

Opportunity:

Growing incidence of chronic diseases

The increasing incidence of chronic diseases, such as diabetes, heart disease, and kidney failure, is driving demand in the market. As these conditions lead to organ dysfunction, the need for innovative solutions like artificial organs and bionic devices becomes more critical. This trend emphasizes the importance of technological advancements to enhance patient care, improve quality of life, and address the challenges posed by a growing population living with chronic health issues.

Threat:

Limited surgical expertise

Limited surgical expertise poses a significant challenge in the market. The complexity of implanting and managing advanced technologies requires highly specialized skills that may not be widely available, particularly in underserved regions. This shortage can lead to delays in patient access to life-saving devices and hinder the overall growth of the market. Addressing this gap through targeted training and education is crucial for enhancing surgical capabilities and improving patient outcomes.

Covid-19 Impact:

The COVID-19 pandemic significantly impacted the market by disrupting supply chains and delaying research and development projects. Hospitals prioritized acute care, leading to postponed elective surgeries, including those involving artificial devices. However, the pandemic also accelerated interest in innovative healthcare solutions, highlighting the need for advanced technologies to address chronic conditions exacerbated by the virus. This shift may drive future growth and investment in the sector as healthcare priorities evolve.

The bioengineered segment is projected to be the largest during the forecast period

The bioengineered segment is projected to account for the largest market share during the projection period due to rising chronic diseases and organ shortages. These innovations aim to mimic natural organ functions while addressing issues like organ shortage and rejection. By combining biological materials with engineering principles, bioengineered products offer the potential for personalized medicine, enhancing patient outcomes and paving the way for more effective treatments in regenerative medicine.

The hospitals segment is expected to have the highest CAGR during the forecast period

The hospitals segment is expected to have the highest CAGR during the extrapolated period. They are essential for clinical trials, where new technologies are tested and refined. Furthermore, hospitals are increasingly adopting advanced artificial organs and bionic devices to improve patient outcomes, particularly for those with chronic conditions. This trend drives demand for innovative solutions, highlighting hospitals' pivotal position in advancing medical technology.

Region with largest share:

North America region is projected to account for the largest market share during the forecast period driven by advanced healthcare infrastructure, significant investments in research and development, and increasing prevalence of chronic diseases. Leading companies and innovative startups are at the forefront of technological advancements, focusing on artificial organs and bionic devices. Additionally, supportive government policies and a strong emphasis on patient care and personalized medicine are further propelling market expansion in the region.

Region with highest CAGR:

Asia Pacific is expected to register the highest growth rate over the forecast period driven by an increasing incidence of disabilities. The market encompasses various segments, including artificial organs like hearts and kidneys, as well as bionic devices such as cochlear implants and orthopedic bionics. The demand for these innovations is further fueled by collaborative efforts among healthcare institutions, universities, and private companies to enhance product offerings and improve patient outcomes

Key players in the market

Some of the key players in Artificial Organs and Bionic market include Medtronic Plc., Boston Scientific Corporation, IVIVA Medical, SynCardia Systems, LLC, Ekso Bionics, Edwards Lifesciences Corporation, ABIOMED, Berlin Heart, Cochlear Ltd., Jarvik Heart, Inc, Zimmer Biomet, Smith & Nephew, Kangaroo Health, Cyberdyne and Hanger Clinic.

Key Developments:

In May 2024, Medtronic Plc. acquired Aortix, a company specializing in advanced circulatory support technologies, to expand its portfolio in artificial organ systems. This acquisition is expected to enhance Medtronic's capabilities in providing innovative solutions for patients with severe cardiac conditions.

In April 2024, Zimmer Biomet Holdings, Inc. announced the successful completion of the world's first robotic-assisted shoulder replacement surgery using its ROSA(R) Shoulder System. The surgery was performed at Mayo Clinic by John W. Sperling, MD, MBA, Professor of Orthopedic Surgery at Mayo Clinic in Rochester, Minnesota, and a key contributor to the ROSA Shoulder development team.

Products Covered:

  • Artificial Organs
  • Bionic Devices

Materials Covered:

  • Biomaterials
  • Metals
  • Polymers
  • Ceramics

Distribution Channels Covered:

  • Direct Sales
  • Third-Party Distributors
  • Online Platforms

Technologies Covered:

  • Conventional
  • Bioengineered
  • Regenerative Medicine
  • Nanotechnology-Based
  • Other Technologies

Applications Covered:

  • Chronic Diseases
  • Trauma and Injury
  • Cosmetic and Aesthetic Procedures
  • Neuroprosthetics
  • Other Applications

End Users Covered:

  • Hospitals
  • Ambulatory Surgical Centers
  • Homecare Settings
  • Rehabilitation Centers
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Technology Analysis
  • 3.8 Application Analysis
  • 3.9 End User Analysis
  • 3.10 Emerging Markets
  • 3.11 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Artificial Organs and Bionic Market, By Product

  • 5.1 Introduction
  • 5.2 Artificial Organs
    • 5.2.1 Artificial Pancreas
    • 5.2.2 Artificial Heart
    • 5.2.3 Artificial Lungs
    • 5.2.4 Artificial Kidney
    • 5.2.5 Artificial Liver
  • 5.3 Bionic Devices
    • 5.3.1 Prosthetic Limbs
    • 5.3.2 Bionic Eyes
    • 5.3.3 Cochlear Implants
    • 5.3.4 Neural Interfaces

6 Global Artificial Organs and Bionic Market, By Material

  • 6.1 Introduction
  • 6.2 Biomaterials
  • 6.3 Metals
  • 6.4 Polymers
  • 6.5 Ceramics

7 Global Artificial Organs and Bionic Market, By Distribution Channel

  • 7.1 Introduction
  • 7.2 Direct Sales
  • 7.3 Third-Party Distributors
  • 7.4 Online Platforms

8 Global Artificial Organs and Bionic Market, By Technology

  • 8.1 Introduction
  • 8.2 Conventional
  • 8.3 Bioengineered
  • 8.4 Regenerative Medicine
  • 8.5 Nanotechnology-Based
  • 8.6 Other Technologies

9 Global Artificial Organs and Bionic Market, By Application

  • 9.1 Introduction
  • 9.2 Chronic Diseases
  • 9.3 Trauma and Injury
  • 9.4 Cosmetic and Aesthetic Procedures
  • 9.5 Neuroprosthetics
  • 9.6 Other Applications

10 Global Artificial Organs and Bionic Market, By End User

  • 10.1 Introduction
  • 10.2 Hospitals
  • 10.3 Ambulatory Surgical Centers
  • 10.4 Homecare Settings
  • 10.5 Rehabilitation Centers
  • 10.6 Other End Users

11 Global Artificial Organs and Bionic Market, By Geography

  • 11.1 Introduction
  • 11.2 North America
    • 11.2.1 US
    • 11.2.2 Canada
    • 11.2.3 Mexico
  • 11.3 Europe
    • 11.3.1 Germany
    • 11.3.2 UK
    • 11.3.3 Italy
    • 11.3.4 France
    • 11.3.5 Spain
    • 11.3.6 Rest of Europe
  • 11.4 Asia Pacific
    • 11.4.1 Japan
    • 11.4.2 China
    • 11.4.3 India
    • 11.4.4 Australia
    • 11.4.5 New Zealand
    • 11.4.6 South Korea
    • 11.4.7 Rest of Asia Pacific
  • 11.5 South America
    • 11.5.1 Argentina
    • 11.5.2 Brazil
    • 11.5.3 Chile
    • 11.5.4 Rest of South America
  • 11.6 Middle East & Africa
    • 11.6.1 Saudi Arabia
    • 11.6.2 UAE
    • 11.6.3 Qatar
    • 11.6.4 South Africa
    • 11.6.5 Rest of Middle East & Africa

12 Key Developments

  • 12.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 12.2 Acquisitions & Mergers
  • 12.3 New Product Launch
  • 12.4 Expansions
  • 12.5 Other Key Strategies

13 Company Profiling

  • 13.1 Medtronic Plc.
  • 13.2 Boston Scientific Corporation
  • 13.3 IVIVA Medical
  • 13.4 SynCardia Systems, LLC
  • 13.5 Ekso Bionics
  • 13.6 Edwards Lifesciences Corporation
  • 13.7 ABIOMED
  • 13.8 Berlin Heart
  • 13.9 Cochlear Ltd.
  • 13.10 Jarvik Heart, Inc
  • 13.11 Zimmer Biomet
  • 13.12 Smith & Nephew
  • 13.13 Kangaroo Health
  • 13.14 Cyberdyne
  • 13.15 Hanger Clinic

List of Tables

  • Table 1 Global Artificial Organs and Bionic Market Outlook, By Region (2022-2030) ($MN)
  • Table 2 Global Artificial Organs and Bionic Market Outlook, By Product (2022-2030) ($MN)
  • Table 3 Global Artificial Organs and Bionic Market Outlook, By Artificial Organs (2022-2030) ($MN)
  • Table 4 Global Artificial Organs and Bionic Market Outlook, By Artificial Pancreas (2022-2030) ($MN)
  • Table 5 Global Artificial Organs and Bionic Market Outlook, By Artificial Heart (2022-2030) ($MN)
  • Table 6 Global Artificial Organs and Bionic Market Outlook, By Artificial Lungs (2022-2030) ($MN)
  • Table 7 Global Artificial Organs and Bionic Market Outlook, By Artificial Kidney (2022-2030) ($MN)
  • Table 8 Global Artificial Organs and Bionic Market Outlook, By Artificial Liver (2022-2030) ($MN)
  • Table 9 Global Artificial Organs and Bionic Market Outlook, By Bionic Devices (2022-2030) ($MN)
  • Table 10 Global Artificial Organs and Bionic Market Outlook, By Prosthetic Limbs (2022-2030) ($MN)
  • Table 11 Global Artificial Organs and Bionic Market Outlook, By Bionic Eyes (2022-2030) ($MN)
  • Table 12 Global Artificial Organs and Bionic Market Outlook, By Cochlear Implants (2022-2030) ($MN)
  • Table 13 Global Artificial Organs and Bionic Market Outlook, By Neural Interfaces (2022-2030) ($MN)
  • Table 14 Global Artificial Organs and Bionic Market Outlook, By Material (2022-2030) ($MN)
  • Table 15 Global Artificial Organs and Bionic Market Outlook, By Biomaterials (2022-2030) ($MN)
  • Table 16 Global Artificial Organs and Bionic Market Outlook, By Metals (2022-2030) ($MN)
  • Table 17 Global Artificial Organs and Bionic Market Outlook, By Polymers (2022-2030) ($MN)
  • Table 18 Global Artificial Organs and Bionic Market Outlook, By Ceramics (2022-2030) ($MN)
  • Table 19 Global Artificial Organs and Bionic Market Outlook, By Distribution Channel (2022-2030) ($MN)
  • Table 20 Global Artificial Organs and Bionic Market Outlook, By Direct Sales (2022-2030) ($MN)
  • Table 21 Global Artificial Organs and Bionic Market Outlook, By Third-Party Distributors (2022-2030) ($MN)
  • Table 22 Global Artificial Organs and Bionic Market Outlook, By Online Platforms (2022-2030) ($MN)
  • Table 23 Global Artificial Organs and Bionic Market Outlook, By Technology (2022-2030) ($MN)
  • Table 24 Global Artificial Organs and Bionic Market Outlook, By Conventional (2022-2030) ($MN)
  • Table 25 Global Artificial Organs and Bionic Market Outlook, By Bioengineered (2022-2030) ($MN)
  • Table 26 Global Artificial Organs and Bionic Market Outlook, By Regenerative Medicine (2022-2030) ($MN)
  • Table 27 Global Artificial Organs and Bionic Market Outlook, By Nanotechnology-Based (2022-2030) ($MN)
  • Table 28 Global Artificial Organs and Bionic Market Outlook, By Other Technologies (2022-2030) ($MN)
  • Table 29 Global Artificial Organs and Bionic Market Outlook, By Application (2022-2030) ($MN)
  • Table 30 Global Artificial Organs and Bionic Market Outlook, By Chronic Diseases (2022-2030) ($MN)
  • Table 31 Global Artificial Organs and Bionic Market Outlook, By Trauma and Injury (2022-2030) ($MN)
  • Table 32 Global Artificial Organs and Bionic Market Outlook, By Cosmetic and Aesthetic Procedures (2022-2030) ($MN)
  • Table 33 Global Artificial Organs and Bionic Market Outlook, By Neuroprosthetics (2022-2030) ($MN)
  • Table 34 Global Artificial Organs and Bionic Market Outlook, By Other Applications (2022-2030) ($MN)
  • Table 35 Global Artificial Organs and Bionic Market Outlook, By End User (2022-2030) ($MN)
  • Table 36 Global Artificial Organs and Bionic Market Outlook, By Hospitals (2022-2030) ($MN)
  • Table 37 Global Artificial Organs and Bionic Market Outlook, By Ambulatory Surgical Centers (2022-2030) ($MN)
  • Table 38 Global Artificial Organs and Bionic Market Outlook, By Homecare Settings (2022-2030) ($MN)
  • Table 39 Global Artificial Organs and Bionic Market Outlook, By Rehabilitation Centers (2022-2030) ($MN)
  • Table 40 Global Artificial Organs and Bionic Market Outlook, By Other End Users (2022-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.